Neuland Laboratories Razão do pagamento

Qual é o Razão do pagamento de Neuland Laboratories?

O Razão do pagamento de Neuland Laboratories Limited é 71.63%

Qual é a definição de Razão do pagamento?



A razão do pagamento é a fração do lucro pago em dividendos aos acionistas.

The payout ratio is calculated by dividing the dividends paid out by the net earnings for a certain period. It is usually expressed as a percentage. The part of the earnings not paid to investors is left for investment to provide for future earnings growth. Investors seeking high current income and limited capital growth prefer companies with high payout ratio. However investors seeking capital growth may prefer lower payout ratio because capital gains are taxed at a lower rate. High growth firms in early life generally have low or zero payout ratios. As they mature, they tend to return more of the earnings back to investors.

Razão do pagamento de empresas na Setor Health Care em BSE em comparação com Neuland Laboratories

O que Neuland Laboratories faz?

Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.

Empresas com razão do pagamento semelhantes a Neuland Laboratories